Israel’s DreaMed Diabetes Treatment Solution Expands To 4 Clinics Across The US
The Israeli company will integrate its AI-based diabetes treatment solution to health clinics in Montana, New York, California, and Florida.
October 12, 2020
DreaMed Receives FDA Approval To Market Diabetes Management Platform
The Israeli developer of diabetes management solutions has won approval from the U.S. Food and Drug Administration to market its Advisor Pro diabetes treatment and management software.
June 20, 2018
